Currently, pursing his postdoctoral study at the University of Texas at Austin in Andreas Matouschek’s group. He is inquisitive in understanding the cellular ubiquitin-proteasome system and proteostasis network. The development of therapeutic modalities, which allow scientists to target aberrant proteins for degradation to treat critical disorders, grabbed his attention to better understand the protein quality control pathways and grow knowledge further on vital degradation machinery, the cellular proteasome. His doctoral research on the synergistic cooperation between the ubiquitin ligases CHN-1 and UFD-2 resulted in a first-author article that landed on the cover of the EMBO Journal and formed the basis of the Ph.D. thesis.